426 related articles for article (PubMed ID: 29055182)
21. ksRepo: a generalized platform for computational drug repositioning.
Brown AS; Kong SW; Kohane IS; Patel CJ
BMC Bioinformatics; 2016 Feb; 17():78. PubMed ID: 26860211
[TBL] [Abstract][Full Text] [Related]
22. A Systematic Framework for Drug Repositioning from Integrated Omics and Drug Phenotype Profiles Using Pathway-Drug Network.
Jadamba E; Shin M
Biomed Res Int; 2016; 2016():7147039. PubMed ID: 28127549
[TBL] [Abstract][Full Text] [Related]
23. Opportunities and technical challenges in next-generation sequencing for diagnosis of rare pediatric diseases.
Bacchelli C; Williams HJ
Expert Rev Mol Diagn; 2016 Oct; 16(10):1073-1082. PubMed ID: 27560481
[TBL] [Abstract][Full Text] [Related]
24. Computational Drug Repositioning: A Lateral Approach to Traditional Drug Discovery?
Sahu NU; Kharkar PS
Curr Top Med Chem; 2016; 16(19):2069-77. PubMed ID: 26881717
[TBL] [Abstract][Full Text] [Related]
25. An integrative approach using real-world data to identify alternative therapeutic uses of existing drugs.
Hosomi K; Fujimoto M; Ushio K; Mao L; Kato J; Takada M
PLoS One; 2018; 13(10):e0204648. PubMed ID: 30300381
[TBL] [Abstract][Full Text] [Related]
26. The Molecular Revolution in Cutaneous Biology: Emerging Landscape in Genomic Dermatology: New Mechanistic Ideas, Gene Editing, and Therapeutic Breakthroughs.
Titeux M; Izmiryan A; Hovnanian A
J Invest Dermatol; 2017 May; 137(5):e123-e129. PubMed ID: 28411843
[TBL] [Abstract][Full Text] [Related]
27. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
Zhao K; So HC
Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
[TBL] [Abstract][Full Text] [Related]
28. Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics.
Pulley JM; Shirey-Rice JK; Lavieri RR; Jerome RN; Zaleski NM; Aronoff DM; Bastarache L; Niu X; Holroyd KJ; Roden DM; Skaar EP; Niswender CM; Marnett LJ; Lindsley CW; Ekstrom LB; Bentley AR; Bernard GR; Hong CC; Denny JC
Assay Drug Dev Technol; 2017 Apr; 15(3):113-119. PubMed ID: 28379727
[TBL] [Abstract][Full Text] [Related]
29. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
Turanli B; Gulfidan G; Arga KY
OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
[TBL] [Abstract][Full Text] [Related]
30. Drug Repositioning to Accelerate Drug Development Using Social Media Data: Computational Study on Parkinson Disease.
Zhao M; Yang CC
J Med Internet Res; 2018 Oct; 20(10):e271. PubMed ID: 30309833
[TBL] [Abstract][Full Text] [Related]
31. New Therapeutic Uses for Existing Drugs.
Austin BA; Gadhia AD
Adv Exp Med Biol; 2017; 1031():233-247. PubMed ID: 29214576
[TBL] [Abstract][Full Text] [Related]
32. Improved Diagnosis and Care for Rare Diseases through Implementation of Precision Public Health Framework.
Baynam G; Bowman F; Lister K; Walker CE; Pachter N; Goldblatt J; Boycott KM; Gahl WA; Kosaki K; Adachi T; Ishii K; Mahede T; McKenzie F; Townshend S; Slee J; Kiraly-Borri C; Vasudevan A; Hawkins A; Broley S; Schofield L; Verhoef H; Groza T; Zankl A; Robinson PN; Haendel M; Brudno M; Mattick JS; Dinger ME; Roscioli T; Cowley MJ; Olry A; Hanauer M; Alkuraya FS; Taruscio D; Posada de la Paz M; Lochmüller H; Bushby K; Thompson R; Hedley V; Lasko P; Mina K; Beilby J; Tifft C; Davis M; Laing NG; Julkowska D; Le Cam Y; Terry SF; Kaufmann P; Eerola I; Norstedt I; Rath A; Suematsu M; Groft SC; Austin CP; Draghia-Akli R; Weeramanthri TS; Molster C; Dawkins HJS
Adv Exp Med Biol; 2017; 1031():55-94. PubMed ID: 29214566
[TBL] [Abstract][Full Text] [Related]
33. Precision medicine in Thailand.
Shotelersuk V; Tongsima S; Pithukpakorn M; Eu-Ahsunthornwattana J; Mahasirimongkol S
Am J Med Genet C Semin Med Genet; 2019 Jun; 181(2):245-253. PubMed ID: 30888117
[TBL] [Abstract][Full Text] [Related]
34. Drug repositioning in sarcomas and other rare tumors.
Lee ATJ; Huang PH; Pollack SM; Jones RL
EBioMedicine; 2016 Apr; 6():4-5. PubMed ID: 27211532
[No Abstract] [Full Text] [Related]
35. Computational drug repositioning using meta-path-based semantic network analysis.
Tian Z; Teng Z; Cheng S; Guo M
BMC Syst Biol; 2018 Dec; 12(Suppl 9):134. PubMed ID: 30598084
[TBL] [Abstract][Full Text] [Related]
36. The Importance of Bioactivation in Computer-Guided Drug Repositioning. Why the Parent Drug is Not Always Enough.
Talevi A
Curr Top Med Chem; 2016; 16(19):2078-87. PubMed ID: 26881710
[TBL] [Abstract][Full Text] [Related]
37. Drug repositioning in SLE: crowd-sourcing, literature-mining and Big Data analysis.
Grammer AC; Ryals MM; Heuer SE; Robl RD; Madamanchi S; Davis LS; Lauwerys B; Catalina MD; Lipsky PE
Lupus; 2016 Sep; 25(10):1150-70. PubMed ID: 27497259
[TBL] [Abstract][Full Text] [Related]
38. Enriching limited information on rare diseases from heterogeneous networks for drug repositioning.
Cao H; Zhang L; Jin B; Cheng S; Wei X; Che C
BMC Med Inform Decis Mak; 2021 Nov; 21(Suppl 9):304. PubMed ID: 34789254
[TBL] [Abstract][Full Text] [Related]
39. Drug repurposing by integrated literature mining and drug-gene-disease triangulation.
Sun P; Guo J; Winnenburg R; Baumbach J
Drug Discov Today; 2017 Apr; 22(4):615-619. PubMed ID: 27780789
[TBL] [Abstract][Full Text] [Related]
40. Review of Drug Repositioning Approaches and Resources.
Xue H; Li J; Xie H; Wang Y
Int J Biol Sci; 2018; 14(10):1232-1244. PubMed ID: 30123072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
